HLA Peptide Length Preferences Control CD8+ T Cell Responses
Melissa J. Rist(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), Nathan P. Croft(Australian Regenerative Medicine Institute), Lucy C. Sullivan(The University of Melbourne), Zhenjun Chen(Peter Doherty Institute), Andrew Welland(Monash University), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Michelle A. Neller(QIMR Berghofer Medical Research Institute), Jamie Rossjohn(Institute of Infection and Immunity), Anthony W. Purcell(Discovery Institute), Stéphanie Gras(La Trobe University), John J. Miles(University of Cambridge), Rebekah M. Brennan(The University of Queensland), Alex Theodossis(Monash University), James McCluskey(Peter Doherty Institute), Jacqueline M. Burrows(QIMR Berghofer Medical Research Institute), Andrëw G. Brööks(The University of Melbourne)
Cited by 73
Related Papers
More than one reason to rethink the use of peptides in vaccine design
|Nature Reviews Drug Discovery|2007|860
Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis
|The Journal of Experimental Medicine|1998|713
Transcriptional signature in microglia associated with Aβ plaque phagocytosis
|Nature Communications|2021|406